MedTrace Logo

Effect of Statin Preloading in STEMI in Improving PCI Outcomes

NCT04974814 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2022-07-21

No results posted yet for this study

Summary

To compare the effect of a single high dose of atorvastatin versus rosuvastatin preloading on microvascular coronary perfusion as determined by CTFC in patients with ST-segment elevation myocardial infarction (STEMI) undergoing PCI.

Conditions

  • ST Elevation Myocardial Infarction

Interventions

DRUG

Rosuvastatin 40mg

patients in active arms will be preloaded with a single 40 mg rosuvastatin in ER before PCI

DRUG

Atorvastatin 80mg

patients in active arms will be preloaded with a single 80 mg atorvastatin in ER before PCI

DRUG

Control Test

patients in control arm will not preloaded with statin in ER before PCI

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Esraa M Adel, bachelor · National Heart Institute

  • Ahmed A El berry, phd · Beni-Suef University

  • Raghda R Hussein, phd · Beni-Suef University

  • Ahmed A Abd el hamid · National Heart Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-26
Primary Completion
2022-10-31
Completion
2023-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04974814 on ClinicalTrials.gov